Advertisement

Topics

Enrollment Begins in U.S. and Abroad for Phase 2 Liver Disease Trial

06:00 EDT 29 Jun 2017 | PharmPro

Genkyotex initiates patient enrollment into Phase 2 trial of GKT831 in primary biliary cholangitis. Initiation at the first investigational center in the U.S. took place following regulatory clearance by the FDA and local Institutional Review Board.
Contributed Author: 
Genkyotex

Original Article: Enrollment Begins in U.S. and Abroad for Phase 2 Liver Disease Trial

NEXT ARTICLE

More From BioPortfolio on "Enrollment Begins in U.S. and Abroad for Phase 2 Liver Disease Trial"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...